Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239068 · ClinicalTrials.gov registry record
CT Residual Gastric Fluid Volume
A clinical trial of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT02239068 is a study of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 76 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02239068, a study of Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: The investigators hypothesize that more than 50% of the patients receiving enteric contrast material (ECM) \< 2 hours of anesthesia/sedation would have residual gastric fluid volume (GFV) \> 0.4 ml/kg. The investigators also hypothesize that measuring GFV by using region of interest in the CT technique is accurate compared to blind aspiration of the gastric contents with a syringe and a multi-orificed orogastric tube.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2011-06-28 |
| Est. Completion | 2023-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02239068
The ClinicalTrials.gov registry entry for NCT02239068 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation appearing as the primary indexed condition, and to 0 interventions.
NCT02239068 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02239068 about?
NCT02239068 is a clinical study titled "CT Residual Gastric Fluid Volume". Hypothesis: The investigators hypothesize that more than 50% of the patients receiving enteric contrast material (ECM) \< 2 hours of anesthesia/sedation would have residual gastric fluid volume (GFV) \> 0.4 ml/kg. The investigators also hypothesize that measuring GFV by using region of interest in t...
What is the current status of trial NCT02239068?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2011-06-28. Estimated completion is 2023-06-01.
What conditions does trial NCT02239068 study?
This clinical trial studies the following conditions: Clinical CT Abdomen/Pelvic With Oral Contrast and Sedation.
Who is sponsoring clinical trial NCT02239068?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02239068 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.